Literature DB >> 16856878

CHMP7, a novel ESCRT-III-related protein, associates with CHMP4b and functions in the endosomal sorting pathway.

Mio Horii1, Hideki Shibata, Ryota Kobayashi, Keiichi Katoh, Chiharu Yorikawa, Jiro Yasuda, Masatoshi Maki.   

Abstract

All CHMPs (charged multivesicular body proteins) reported to date have common features: they all contain approx. 200 amino acid residues, have coiled-coil regions and have a biased distribution of charged residues (basic N-terminal and acidic C-terminal halves). Yeast orthologues of CHMPs, including an ESCRT-III component Snf7, are required for the sorting of cargo proteins to intraluminal vesicles of multivesicular bodies. We have characterized a novel human ESCRT-III-related protein, designated CHMP7, which consists of 453 amino acid residues. CHMP7 contains an SNF7 domain and a distantly SNF7-related domain in its C-terminal half and N-terminal half respectively. Among the ten CHMP proteins classified previously in six subfamilies (CHMP1-CHMP6), the C-terminal SNF7 domain of CHMP7 is most similar to the SNF7 domain of CHMP6, which associates with CHMP4 proteins and EAP20, a component of ESCRT-II. Pull-down assays using lysates of HEK-293T (human embryonic kidney) cells that overexpressed Strep-tagged CHMP7 and GFP (green fluorescent protein)-fused CHMP4b (also named Shax1) revealed a positive interaction between the C-terminal half of CHMP7 and CHMP4b. However, interaction was not observed between CHMP7 and EAP20. Confocal fluorescence microscopic analyses revealed that FLAG-CHMP7 is distributed in HeLa cells diffusely throughout the cytoplasm, but with some accumulation, especially in the perinuclear area. The distribution of FLAG-CHMP7 was altered to a cytoplasmic punctate pattern by overexpression of either CHMP4b-GFP or GFP-Vps4B(E235Q), a dominant-negative mutant of the AAA (ATPase associated with various cellular activities) Vps4B, and partially co-localized with them. Ubiquitinated proteins and endocytosed EGF accumulated in GFP-CHMP7-expressing cells. A dominant-negative effect of overexpressed GFP-CHMP7 was also observed in the release of virus-like particles from HEK-293T cells that transiently expressed the MLV (murine leukaemia virus) Gag protein. These results suggest that CHMP7, a novel CHMP4-associated ESCRT-III-related protein, functions in the endosomal sorting pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16856878      PMCID: PMC1635454          DOI: 10.1042/BJ20060897

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

Review 1.  A protein's final ESCRT.

Authors:  Markus Babst
Journal:  Traffic       Date:  2005-01       Impact factor: 6.215

2.  The hereditary spastic paraplegia protein spastin interacts with the ESCRT-III complex-associated endosomal protein CHMP1B.

Authors:  Evan Reid; James Connell; Thomas L Edwards; Simon Duley; Stephanie E Brown; Christopher M Sanderson
Journal:  Hum Mol Genet       Date:  2004-11-10       Impact factor: 6.150

3.  Tsg101 and Alix interact with murine leukemia virus Gag and cooperate with Nedd4 ubiquitin ligases during budding.

Authors:  Carolina Segura-Morales; Christina Pescia; Christine Chatellard-Causse; Remy Sadoul; Edouard Bertrand; Eugenia Basyuk
Journal:  J Biol Chem       Date:  2005-05-21       Impact factor: 5.157

Review 4.  Intracellular trafficking of HIV-1 Gag: how Gag interacts with cell membranes and makes viral particles.

Authors:  Marilyn D Resh
Journal:  AIDS Rev       Date:  2005 Apr-Jun       Impact factor: 2.500

5.  The Vps4p AAA ATPase regulates membrane association of a Vps protein complex required for normal endosome function.

Authors:  M Babst; B Wendland; E J Estepa; S D Emr
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

6.  The penta-EF-hand protein ALG-2 interacts directly with the ESCRT-I component TSG101, and Ca2+-dependently co-localizes to aberrant endosomes with dominant-negative AAA ATPase SKD1/Vps4B.

Authors:  Keiichi Katoh; Hidenori Suzuki; Yoshinori Terasawa; Takako Mizuno; Jiro Yasuda; Hideki Shibata; Masatoshi Maki
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

7.  Interaction of the mammalian endosomal sorting complex required for transport (ESCRT) III protein hSnf7-1 with itself, membranes, and the AAA+ ATPase SKD1.

Authors:  Yuan Lin; Lisa A Kimpler; Teresa V Naismith; Joshua M Lauer; Phyllis I Hanson
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

8.  Human CHMP6, a myristoylated ESCRT-III protein, interacts directly with an ESCRT-II component EAP20 and regulates endosomal cargo sorting.

Authors:  Chiharu Yorikawa; Hideki Shibata; Satoshi Waguri; Kazumi Hatta; Mio Horii; Keiichi Katoh; Toshihide Kobayashi; Yasuo Uchiyama; Masatoshi Maki
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

9.  ESCRT-II, an endosome-associated complex required for protein sorting: crystal structure and interactions with ESCRT-III and membranes.

Authors:  Hsiangling Teo; Olga Perisic; Beatriz González; Roger L Williams
Journal:  Dev Cell       Date:  2004-10       Impact factor: 12.270

10.  Degradation of endocytosed epidermal growth factor and virally ubiquitinated major histocompatibility complex class I is independent of mammalian ESCRTII.

Authors:  Katherine Bowers; Siân C Piper; Melissa A Edeling; Sally R Gray; David J Owen; Paul J Lehner; J Paul Luzio
Journal:  J Biol Chem       Date:  2005-12-20       Impact factor: 5.157

View more
  31 in total

1.  Two distinct modes of ESCRT-III recognition are required for VPS4 functions in lysosomal protein targeting and HIV-1 budding.

Authors:  Collin Kieffer; Jack J Skalicky; Eiji Morita; Ivana De Domenico; Diane M Ward; Jerry Kaplan; Wesley I Sundquist
Journal:  Dev Cell       Date:  2008-07       Impact factor: 12.270

2.  No strings attached: the ESCRT machinery in viral budding and cytokinesis.

Authors:  Bethan McDonald; Juan Martin-Serrano
Journal:  J Cell Sci       Date:  2009-07-01       Impact factor: 5.285

3.  Structural basis for autoinhibition of ESCRT-III CHMP3.

Authors:  Suman Lata; Manfred Roessle; Julianna Solomons; Marc Jamin; Heinrich G Gottlinger; Dmitri I Svergun; Winfried Weissenhorn
Journal:  J Mol Biol       Date:  2008-03-20       Impact factor: 5.469

4.  Spastin and ESCRT-III coordinate mitotic spindle disassembly and nuclear envelope sealing.

Authors:  Marina Vietri; Kay O Schink; Coen Campsteijn; Catherine Sem Wegner; Sebastian W Schultz; Liliane Christ; Sigrid B Thoresen; Andreas Brech; Camilla Raiborg; Harald Stenmark
Journal:  Nature       Date:  2015-06-03       Impact factor: 49.962

Review 5.  The ESCRT machinery: from the plasma membrane to endosomes and back again.

Authors:  Amber L Schuh; Anjon Audhya
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-01-24       Impact factor: 8.250

6.  Chm7 and Heh1 collaborate to link nuclear pore complex quality control with nuclear envelope sealing.

Authors:  Brant M Webster; David J Thaller; Jens Jäger; Sarah E Ochmann; Sapan Borah; C Patrick Lusk
Journal:  EMBO J       Date:  2016-10-12       Impact factor: 11.598

7.  Evidence for a Nonendosomal Function of the Saccharomyces cerevisiae ESCRT-III-Like Protein Chm7.

Authors:  Iva Bauer; Thomas Brune; Richard Preiss; Ralf Kölling
Journal:  Genetics       Date:  2015-10-28       Impact factor: 4.562

8.  Novel Host Proteins and Signaling Pathways in Enteropathogenic E. coli Pathogenesis Identified by Global Phosphoproteome Analysis.

Authors:  Roland Scholz; Koshi Imami; Nichollas E Scott; William S Trimble; Leonard J Foster; B Brett Finlay
Journal:  Mol Cell Proteomics       Date:  2015-05-05       Impact factor: 5.911

Review 9.  Regulation of Vps4 ATPase activity by ESCRT-III.

Authors:  Brian A Davies; Ishara F Azmi; David J Katzmann
Journal:  Biochem Soc Trans       Date:  2009-02       Impact factor: 5.407

10.  Herpes simplex virus type 1 production requires a functional ESCRT-III complex but is independent of TSG101 and ALIX expression.

Authors:  Tobias Pawliczek; Colin M Crump
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.